Expanded Safety Analysis of Pevonedistat, a First-in-class NEDD8-activating Enzyme Inhibitor, in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes
BLOOD CANCER JOURNAL（2017）
Key words
Acute myeloid leukaemia,Drug development,Biomedicine,general,Cancer Research,Oncology,Hematology
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined